Medical Center MedConsult - Burgas
- Address
- Ulitsa Stefan Stambolov 73, 8000 Burgas, Bulgaria
Cardiovascular Diseases
At Medical Center MedConsult - Burgas, clinical research in cardiovascular diseases focuses on conditions such as hypertension, established cardiovascular disease, high cardiovascular risk, acute myocardial infarction, and heart failure linked with obesity. These studies aim to test new approaches that may reduce major cardiac events, improve symptom control, and support better long-term heart health.
- Testing new therapies to lower the risk of heart attacks, stroke, and heart failure events
- Evaluating treatment options for hypertension and high-risk cardiovascular patients
- Studying care approaches for HFpEF, HFmrEF, and pulmonary hypertension
Several trials also explore whether anti-inflammatory and metabolic treatments can improve outcomes in people with recent cardiac events or chronic cardiovascular disease.
Oncology
The site conducts oncology research in breast cancer, non-small cell lung cancer, and blood cancers such as chronic lymphocytic leukemia, multiple myeloma, and non-Hodgkin lymphoma. These trials are designed to assess new cancer treatments, compare them with established therapies, and improve disease control for patients with advanced or hard-to-treat malignancies.
- Evaluating new treatment strategies for advanced breast cancer
- Studying therapies for lung cancer and metastatic disease
- Supporting infection prevention research in patients with blood cancers
This oncology portfolio at Medical Center MedConsult - Burgas reflects a strong focus on both solid tumors and hematologic malignancies.
Immune and Inflammatory Diseases
Research in immune system diseases includes psoriatic arthritis, atopic dermatitis, hidradenitis suppurativa, and Sjögren’s syndrome. The trials are aimed at finding treatments that can reduce inflammation, ease symptoms, and improve quality of life in chronic autoimmune and skin-related conditions.
- Testing therapies for psoriatic arthritis and joint inflammation
- Evaluating treatment effectiveness in atopic dermatitis and hidradenitis suppurativa
- Assessing long-term safety and symptom relief in Sjögren’s syndrome
These studies help expand options for patients living with persistent immune-mediated disease.
Digestive and Liver Diseases
Clinical trials in digestive system diseases and liver-related conditions address chronic rhinosinusitis, Clostridioides difficile infection, alcoholic liver disease, and MASLD/MASH. The main goal is to improve treatment effectiveness, reduce recurrence or progression, and support better management of chronic gastrointestinal and liver disorders.
- Preventing recurrence of Clostridioides difficile infection
- Studying therapies for chronic rhinosinusitis symptoms
- Exploring treatment support for metabolic liver disease and alcohol-related liver injury
These investigations broaden care options for patients with ongoing digestive and liver health challenges.
Virus and Infection-Related Research
The site also participates in studies of virus diseases and bacterial infections, including COVID-19 and chronic viral hepatitis B. In addition, some trials focus on preventing serious infections in vulnerable patients with blood cancers. The purpose is to evaluate whether new therapies can reduce complications, improve recovery, and strengthen infection control.
- Assessing treatments for SARS-CoV-2 infection
- Studying care options for chronic viral hepatitis B
- Testing infection prevention strategies in patients at higher risk of bacterial illness
These trials combine infectious disease research with supportive care for patients who are medically fragile.
Metabolic and Endocrine-Related Conditions
Research in nutritional and metabolic diseases includes obesity alongside cardiovascular and liver-related conditions. At this Burgas research site, these trials are generally designed to examine whether new treatments can improve weight-related health risks, support heart protection, and address metabolic complications linked to chronic disease.
- Evaluating therapies for obesity with related heart disease
- Studying approaches that may lower metabolic and cardiovascular risk together
- Assessing treatment impact in patients with overlapping weight and heart conditions
This area connects metabolic care with broader chronic disease management.
Musculoskeletal and Skin-Related Research
Trials in musculoskeletal diseases and skin and connective tissue diseases include inflammatory conditions such as psoriatic arthritis, atopic dermatitis, and hidradenitis suppurativa. The research is focused on testing therapies that can reduce pain, inflammation, skin lesions, and other burdensome symptoms.
- Improving control of joint and skin inflammation
- Testing new options for chronic dermatologic disease
- Evaluating whether treatments can provide sustained symptom relief
These studies support better care for patients with long-lasting inflammatory disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 7 therapeutic areas and 15 of 33 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 12 by active trials.
- 1Novo Nordisk A/S1active
lock +11 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novo Nordisk A/S3trials
lock +3 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medical Center MedConsult - Burgas
lock Showing 1 of 20 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| 22104: A Randomized, Double-blind, Placebo-controlled, Multicenter Phase 2b/3 Study to Evaluate the Efficacy and Safety of Izokibep in Subjects with Active Psoriatic Arthritis | Acelyrin Inc. | Phase IV | Not Recruiting | Apr 2023 | Oct 2024 |
IMP list
lock Showing 1 of 33 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ianalumab | 2 | Unknown | 2022-08-04 | 2023-10-27 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.